Cambridge-based Oval Medical Technologies Limited (“Oval Medical”) has recently collaborated on the Cambridge Venture Project (CVP), part of the MBA programme at the Judge Business School, University of Cambridge. The Cambridge Venture Project provides a unique opportunity for MBA students … Continue reading →

Cambridge, UK. Wednesday, 16 November 2011 – Oval Medical Technologies Ltd., (“Oval”) the pioneering autoinjector development company, today announced that they have successfully completed a £2 million investment from AptarGroup, Inc. (NYSE: ATR) (“Aptar”) . Additionally, Aptar has become Oval’s … Continue reading →

Cambridge, UK. The autoinjector development company Oval Medical Technologies ltd, has today announced further expansion with two new appointments of a Programme Manager and a Design Engineer. Alison Kwok joins the company in the capacity of Programme Manager from Owen … Continue reading →

Cambridge, UK. Oval Medical Technologies Ltd., the company developing the next generation of autoinjector technology, announced today that they have entered into two deals with pharmaceutical companies who are putting Oval’s primary drug containment technology through feasibility trials. Oval’s CEO … Continue reading →

Cambridge, UK. 10th January 2011. Oval Medical Technologies Ltd., the Cambridge based autoinjector company today announced results from two user studies in which Oval’s novel, proprietary autoinjector clearly demonstrated superiority compared with two well-known autoinjector devices currently on the market. … Continue reading →

Cambridge, UK – January 6th 2011. Oval Medical Technologies Ltd, the company developing the next generation of autoinjectors, announced that it successfully completed a second oversubscribed funding round. This was again led by The Cambridge Angels, with participation from Cambridge … Continue reading →

Press Release – Cambridge, UK. 05 October 2010: Today Oval Medical Technologies, the specialist medical device company that is designing and developing the next generation of autoinjectors, announced that Mr. Peter Keen has joined the Company as Chairman of the … Continue reading →

Cambridge UK – 27th July 2010 Today, Oval Medical is pleased to announce that the on-going success of developing its revolutionary autoinjector and syringe technologies, has lead to the company’s second expansion less than a year after the company was … Continue reading →

Cambridge UK – May 12th 2010 Oval Medical the advanced autoinjector company, that recently announced an over-subscribed seed funding round, has today announced that it has made substantial progress with its novel technologies. The Company has now developed a prototype … Continue reading →

Cambridge UK – March 1st 2010 Oval Medical today announces that it has raised £492,000 in an over-subscribed seed funding round to advance the development of its novel autoinjector and pre-filled syringe technology. The round was led by The Cambridge … Continue reading →